Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Thoracic Oncology"
DOI: 10.1016/j.jtho.2019.12.038
Abstract: KRASG12C(ON) inhibitors with agents targeting pathway nodes both upand downstream of RAS, as well as other parallel pathways, can drive combination benefit in distinct cancer histotypes. Tri-complex inhibitors that target the active, GTP-bound form of…
read more here.
Keywords:
cancer;
subtypes resolve;
transcriptional subtypes;
a09 transcriptional ... See more keywords